共 417 条
[21]
Mascola JR(1990)Production, mapping and biological characterisation of monoclonal antibodies to the core protein (p24) of the human immunodeficiency virus type 1 AIFO 5 24-11001
[22]
Morris L(2008)Importance of protease cleavage sites within and flanking human immunodeficiency virus type 1 transframe protein p6* for spatiotemporal regulation of protease activation J Virol 82 4573-10826
[23]
Chan DC(2001)Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein J Virol 75 10991-11519
[24]
Kim PS(2000)Concerted action of multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression J Virol 74 10822-1491
[25]
Weissenhorn W(2005)Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays Curr Protoc Immunol Chapter 12 Unit 12.11-10878
[26]
Dessen A(2011)Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals J Virol 85 11502-140
[27]
Harrison SC(2013)Detailed topology mapping reveals substantial exposure of the “cytoplasmic” C-terminal tail (CTT) sequences in HIV-1 Env proteins at the cell surface PLoS One 8 e65220-262
[28]
Skehel JJ(2010)Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies Nat Struct Mol Biol 17 1486-8762
[29]
Wiley DC(2007)Incorporation of High Levels of Chimeric Human Immunodeficiency Virus Envelope Glycoproteins into Virus-Like Particles J Virol 81 10869-45820
[30]
Huang J(1996)Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles Virology 220 128-693